Thursday November 20, 2008
Search Directorship.com for:
Top Tags:
accounting & audit board administration calpers ceo ceo succession compensation corporate governance credit crisis director news executive compensation korean investment corp. kuwait investment authority merrill lynch mizuho corporate bank of japan proxy say on pay sec shareholders strategy & leadership
 The Directorship Boardroom & Economic ForumTo register for the annual global gathering of leading board directors and corporate governance influentials click here.
September 01, 2008 Q&A with Deloitte’s M&A leader for Healthcare and Life SciencesAs the National Healthcare & Life Sciences Industry Leader of Deloitte’s M&A Transaction Services, Philip E. Pfrang has advised clients on more than 400 completed and proposed transactions and has extensive experience in cross–border and multinational deals.
Directorship spoke with Pfrang about trends in the healthcare and life sciences marketplace and his prognostications for M&A in the near term.
Tags: m&a (38) healthcare (1) life sciences (1) trends (1) trends for directors (1) survey (9) deloitte (7) phil pfrang (1)
|
        
  Related ContentMagazine ArticlesRisk Management in Emerging MarketsQ&A with Deloitte’s M&A leader for Healthcare and Life Sciences Shareholder News ArticlesAirline Shareholders Approve Merger DealSpanish Bank to Acquire Sovereign Buyout Bids Go South as Market Falters |
